Caxton Associates (New York)’s Tricida, Inc. Common Stock TCDA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-32,519
Closed -$315K 724
2022
Q2
$315K Hold
32,519
0.03% 370
2022
Q1
$267K Sell
32,519
-36,082
-53% -$326K 0.02% 387
2021
Q4
$656K Buy
+68,601
New +$442K 0.07% 207

Other funds holding TCDA

Caxton Associates (New York)'s TCDA Position: Q3 2022 in Review

Caxton Associates (New York) sold out of Tricida, Inc. Common Stock (TCDA) in Q3 2022, closing a stake of 32,519 shares — an estimated $315K sold.

Caxton Associates (New York) first reported a position in TCDA in Q4 2021 and held it in 3 quarters. The position peaked at $656K in Q4 2021. 120 funds tracked by Wall St. Rank hold TCDA as of Q3 2022.

  • Caxton Associates (New York) reported no remaining Tricida, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • Caxton Associates (New York) sold 32,519 Tricida, Inc. Common Stock shares in Q3 2022, an estimated $315K.
  • Caxton Associates (New York) first reported a position in Tricida, Inc. Common Stock in Q4 2021 and held it in 3 quarters.
  • Caxton Associates (New York)'s Tricida, Inc. Common Stock position peaked at $656K in Q4 2021.
  • 120 funds tracked by Wall St. Rank held Tricida, Inc. Common Stock as of Q3 2022.

Based on Caxton Associates (New York)'s 13F filing for Q3 2022, filed 14 Nov 2022.